Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials.

Willer DO, Oostvogels L, Cunningham AL, Gervais P, Gorfinkel I, Hyung Kim J, Talarico C, Wascotte V, Zahaf T, Colindres R, Schuind A; ZOE 50/70 study groups.

Vaccine. 2019 Oct 8;37(43):6262-6267. doi: 10.1016/j.vaccine.2019.09.028. Epub 2019 Sep 16.

2.

A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines.

McGirr A, Iqbal SM, Izurieta P, Talarico C, Luijken J, Redig J, Newson RS.

Hum Vaccin Immunother. 2019 Jun 19:1-12. doi: 10.1080/21645515.2019.1612667. [Epub ahead of print]

PMID:
31216216
3.

Gallstone ileus of the sigmoid colon. A case repor.

Petracca G, Ruggiero M, Zappia A, Lebrino C, Zappia F, Talarico C.

Ann Ital Chir. 2019 Mar 28;8. pii: S2239253X19027609.

PMID:
30946025
4.

Dolutegravir-Based Antiretroviral Therapy for Patients Co-Infected with Tuberculosis and Hiv: A Multicenter, Noncomparative, Open-Label, Randomized Trial.

Dooley KE, Kaplan R, Mwelase N, Grinsztejn B, Ticona E, Lacerda M, Sued O, Belonosova E, Ait-Khaled M, Angelis K, Brown D, Singh R, Talarico CL, Tenorio AR, Keegan MR, Aboud M; INSPIRING study group.

Clin Infect Dis. 2019 Mar 28. pii: ciz256. doi: 10.1093/cid/ciz256. [Epub ahead of print]

PMID:
30918967
5.

Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques.

Costa G, Rocca R, Corona A, Grandi N, Moraca F, Romeo I, Talarico C, Gagliardi MG, Ambrosio FA, Ortuso F, Alcaro S, Distinto S, Maccioni E, Tramontano E, Artese A.

Eur J Med Chem. 2019 Jan 1;161:1-10. doi: 10.1016/j.ejmech.2018.10.029. Epub 2018 Oct 13.

PMID:
30342421
6.

The choice of analytical methodology can alter conclusions regarding herd effects of paediatric pneumococcal vaccination programmes.

Pirçon JY, Talarico CA, Bollaerts K, Hausdorff WP, Clarke CJ.

Vaccine. 2018 Nov 12;36(46):6933-6943. doi: 10.1016/j.vaccine.2018.10.003. Epub 2018 Oct 11.

7.

In Silico Identification of Piperidinyl-amine Derivatives as Novel Dual Binders of Oncogene c-myc/c-Kit G-quadruplexes.

Rocca R, Moraca F, Costa G, Talarico C, Ortuso F, Da Ros S, Nicoletto G, Sissi C, Alcaro S, Artese A.

ACS Med Chem Lett. 2018 Jul 10;9(8):848-853. doi: 10.1021/acsmedchemlett.8b00275. eCollection 2018 Aug 9.

8.

Authors' response to correspondence for EPI-STREP-064 publication.

Montaner AE, de Lomas JG, Asensi JRV, de la Cruz OA, de la Serna Blázquez O, Burruchaga MS, López PM, Vernetta AT, Feng Y, Van Dyke MK, Reyes J, Garcia-Corbeira P, Talarico CA; EPI-Strep-064 study group.

Eur J Pediatr. 2018 Sep;177(9):1411-1412. doi: 10.1007/s00431-018-3180-4. Epub 2018 Jun 14. No abstract available.

9.

The Mu.Ta.Lig. Chemotheca: A Community-Populated Molecular Database for Multi-Target Ligands Identification and Compound-Repurposing.

Ortuso F, Bagetta D, Maruca A, Talarico C, Bolognesi ML, Haider N, Borges F, Bryant S, Langer T, Senderowitz H, Alcaro S.

Front Chem. 2018 Apr 19;6:130. doi: 10.3389/fchem.2018.00130. eCollection 2018.

10.

Real-life 3D therapy failure: Analysis of NS5A 93H RAS plus 108 K polymorphism in complex with ombitasvir by molecular modeling.

Marascio N, Pavia G, Romeo I, Talarico C, Di Salvo S, Reale M, Marano V, Barreca GS, Fabiani F, Perrotti N, De Siena M, Giancotti F, Gravina T, Alcaro S, Artese A, Torti C, Liberto MC, Focà A.

J Med Virol. 2018 Jul;90(7):1257-1263. doi: 10.1002/jmv.25073. Epub 2018 Mar 31.

PMID:
29575060
11.

Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance.

Malet I, Ambrosio FA, Subra F, Herrmann B, Leh H, Bouger MC, Artese A, Katlama C, Talarico C, Romeo I, Alcaro S, Costa G, Deprez E, Calvez V, Marcelin AG, Delelis O.

J Antimicrob Chemother. 2018 May 1;73(5):1158-1166. doi: 10.1093/jac/dkx529.

PMID:
29373677
12.

Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain.

Escribano Montaner A, García de Lomas J, Villa Asensi JR, Asensio de la Cruz O, de la Serna Blázquez O, Santiago Burruchaga M, Mondéjar López P, Torrent Vernetta A, Feng Y, Van Dyke MK, Reyes J, Garcia-Corbeira P, Talarico CA; EPI-Strep-064 study group.

Eur J Pediatr. 2018 Feb;177(2):181-192. doi: 10.1007/s00431-017-3044-3. Epub 2017 Dec 29.

13.

The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells.

Catalogna G, Talarico C, Dattilo V, Gangemi V, Calabria F, D'Antona L, Schenone S, Musumeci F, Bianco C, Perrotti N, Amato R, Cascini GL.

Cell Physiol Biochem. 2017;43(1):108-119. doi: 10.1159/000480328. Epub 2017 Aug 25.

14.

Molecular recognition of a carboxy pyridostatin toward G-quadruplex structures: Why does it prefer RNA?

Rocca R, Talarico C, Moraca F, Costa G, Romeo I, Ortuso F, Alcaro S, Artese A.

Chem Biol Drug Des. 2017 Nov;90(5):919-925. doi: 10.1111/cbdd.13015. Epub 2017 Jun 6.

PMID:
28459507
15.

Gallstone ileus. A case treated with minilaparotomy and a review of the literature.

Zappia F, Petracca G, Talarico CA.

Ann Ital Chir. 2017 Mar 29;6. pii: S2239253X1702535X. Review.

PMID:
28401880
16.

SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation.

Dattilo V, D'Antona L, Talarico C, Capula M, Catalogna G, Iuliano R, Schenone S, Roperto S, Bianco C, Perrotti N, Amato R.

Sci Rep. 2017 Mar 30;7:45361. doi: 10.1038/srep45361.

17.

Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization.

Rocca R, Moraca F, Costa G, Nadai M, Scalabrin M, Talarico C, Distinto S, Maccioni E, Ortuso F, Artese A, Alcaro S, Richter SN.

Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1329-1340. doi: 10.1016/j.bbagen.2016.12.023. Epub 2016 Dec 23.

PMID:
28025082
18.

SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition.

Talarico C, Dattilo V, D'Antona L, Menniti M, Bianco C, Ortuso F, Alcaro S, Schenone S, Perrotti N, Amato R.

Cell Physiol Biochem. 2016;39(5):1863-1876. Epub 2016 Oct 24. Review.

19.

A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences.

Costa G, Rocca R, Moraca F, Talarico C, Romeo I, Ortuso F, Alcaro S, Artese A.

Mol Inform. 2016 Sep;35(8-9):391-402. doi: 10.1002/minf.201501040. Epub 2016 Jun 24.

PMID:
27546043
20.

SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.

Talarico C, Dattilo V, D'Antona L, Barone A, Amodio N, Belviso S, Musumeci F, Abbruzzese C, Bianco C, Trapasso F, Schenone S, Alcaro S, Ortuso F, Florio T, Paggi MG, Perrotti N, Amato R.

Oncotarget. 2016 Mar 29;7(13):15868-84. doi: 10.18632/oncotarget.7520.

21.

Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy.

Talarico C, D'Antona L, Scumaci D, Barone A, Gigliotti F, Fiumara CV, Dattilo V, Gallo E, Visca P, Ortuso F, Abbruzzese C, Botta L, Schenone S, Cuda G, Alcaro S, Bianco C, Lavia P, Paggi MG, Perrotti N, Amato R.

Oncotarget. 2015 Nov 10;6(35):37511-25. doi: 10.18632/oncotarget.5527.

22.

SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation.

D'Antona L, Amato R, Talarico C, Ortuso F, Menniti M, Dattilo V, Iuliano R, Gigliotti F, Artese A, Costa G, Schenone S, Musumeci F, Abbruzzese C, Botta L, Trapasso F, Alcaro S, Paggi MG, Perrotti N.

Cell Physiol Biochem. 2015;35(5):2006-18. doi: 10.1159/000374008. Epub 2015 Mar 27.

23.

In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold.

Ortuso F, Amato R, Artese A, D'antona L, Costa G, Talarico C, Gigliotti F, Bianco C, Trapasso F, Schenone S, Musumeci F, Botta L, Perrotti N, Alcaro S.

J Chem Inf Model. 2014 Jul 28;54(7):1828-32. doi: 10.1021/ci500235f. Epub 2014 Jun 13.

PMID:
24896223
24.

Evaluation of the metabolism of propranolol by linear ion trap technology in mouse, rat, dog, monkey, and human cryopreserved hepatocytes.

Baughman TM, Talarico CL, Soglia JR.

Rapid Commun Mass Spectrom. 2009 Jul;23(14):2146-50. doi: 10.1002/rcm.4130.

PMID:
19517456
25.

GSK983: a novel compound with broad-spectrum antiviral activity.

Harvey R, Brown K, Zhang Q, Gartland M, Walton L, Talarico C, Lawrence W, Selleseth D, Coffield N, Leary J, Moniri K, Singer S, Strum J, Gudmundsson K, Biron K, Romines KR, Sethna P.

Antiviral Res. 2009 Apr;82(1):1-11. doi: 10.1016/j.antiviral.2008.12.015. Epub 2009 Jan 31.

PMID:
19187793
26.

Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study.

Calzolari F, Sartori PV, Talarico C, Parmeggiani D, Beretta E, Pezzullo L, Bovo G, Sperlongano P, Monacelli M, Lucchini R, Misso C, Gurrado A, D'Ajello M, Uggeri F, Puxeddu E, Nasi P, Testini M, Rosato L, Barbarisio A, Avenia N.

Anticancer Res. 2008 Sep-Oct;28(5B):2885-8.

27.
28.

The ACTIVE (Acute Cholecystitis Trial Invasive Versus Endoscopic) study: multicenter randomized, double-blind, controlled trial of laparoscopic (LC) versus open (LTC) surgery for acute cholecystitis (AC) in adults.

Catena F, Ansaloni L, Di Saverio S, Gazzotti F, Gagliardi S, Coccolini F, D'Alessandro L, Ercolani G, Talarico C, Bassi UA, Leone L, Calzolari F, Pinna AD.

Trials. 2008 Jan 10;9:1. doi: 10.1186/1745-6215-9-1.

29.

[Preoperative diagnosis of incidental carcinoma in multinodular goitre by means of electromagnetic interactions].

Sacco R, Innaro N, Pata F, Lucisano AM, Talarico C, Aversa S.

Chir Ital. 2007 Mar-Apr;59(2):247-51. Italian.

PMID:
17500182
30.

Surgical management of substernal goitres. When is sternotomy inevitable?

Flati G, De Giacomo T, Porowska B, Flati D, Gaj F, Talarico C, Antonellis F, Diana M, Berloco PB.

Clin Ter. 2005 Sep-Oct;156(5):191-5.

PMID:
16382967
31.

[Tardive cecal metastasis from ovarian cancer: a case report].

Talarico C, Casella C, Gambarotti M.

Ann Ital Chir. 2004 Nov-Dec;75(6):697-700. Italian.

PMID:
15960367
32.

[Severe hypercalcemia due to acute primary hyperparathyroidism: role if parathyroidectomy].

Casella C, Talarico C, Nascimbeni R, Di Fabio F, Salerni B.

Ann Ital Chir. 2004 Mar-Apr;75(2):235-9. Italian.

PMID:
15386996
33.

[Hypoparathyroidism following total thyroidectomy: prognostic value of intraoperative parathyroid hormone assay].

Casella C, Talarico C, Di Fabio F, Bugari G, Iacobello C, Albertini A, Salerni B.

Ann Ital Chir. 2004 Jan-Feb;75(1):23-7. Italian.

PMID:
15283383
34.

[The role of color flow-Doppler ultrasonography in the diagnosis of nodular goiter].

Casella C, Talarico C, La Pinta M, Nascimbeni R, Di Fabio F, Salerni B.

Ann Ital Chir. 2003 Sep-Oct;74(5):495-9; discussion 499-500. Italian.

PMID:
15139703
35.

Photostability of naturally occurring whitening agents in cosmetic microemulsions.

Gallarate M, Carlotti ME, Trotta M, Grande AE, Talarico C.

J Cosmet Sci. 2004 Mar-Apr;55(2):139-48.

PMID:
15131725
36.

[The role of color-Doppler ultrasonography in preoperative study of hyperparathyroidism].

Casella C, Talarico C, La Pinta M, Nascimbeni R, Salerni B.

Ann Ital Chir. 2002 Nov-Dec;73(6):563-8; discussion 569. Italian.

PMID:
12820579
37.

Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication.

Selleseth DW, Talarico CL, Miller T, Lutz MW, Biron KK, Harvey RJ.

Antimicrob Agents Chemother. 2003 Apr;47(4):1468-71.

38.

Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding.

Lalezari JP, Aberg JA, Wang LH, Wire MB, Miner R, Snowden W, Talarico CL, Shaw S, Jacobson MA, Drew WL.

Antimicrob Agents Chemother. 2002 Sep;46(9):2969-76.

39.

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.

Biron KK, Harvey RJ, Chamberlain SC, Good SS, Smith AA 3rd, Davis MG, Talarico CL, Miller WH, Ferris R, Dornsife RE, Stanat SC, Drach JC, Townsend LB, Koszalka GW.

Antimicrob Agents Chemother. 2002 Aug;46(8):2365-72.

40.

Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.

McSharry JJ, McDonough A, Olson B, Talarico C, Davis M, Biron KK.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1279-81.

41.

Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistance.

Balfour HH Jr, Edelman CK, Anderson RS, Reed NV, Slivken RM, Marmor LH, Dix L, Aeppli D, Talarico CL.

Pediatr Infect Dis J. 2001 Oct;20(10):919-26.

PMID:
11642624
42.

[Lymphangiomatosis of the spleen. Report of a clinical case].

Talarico C, Cerasoli V, Mancini B, Mulieri G, Cancellario D'Alena F, Montemurro L, Verna F.

Ann Ital Chir. 2000 Sep-Oct;71(5):599-602. Review. Italian.

PMID:
11217478
43.

[Benign thyroid disease: 20-year experience in surgical therapy].

Zaraca F, Di Paola M, Gossetti F, Proposito D, Filippoussis P, Montemurro L, Mancini B, Gallina S, Talarico E, Talarico C, Lazzaro M, Mulieri G, Flati D, Flati G, Carboni M.

Chir Ital. 2000 Jan-Feb;52(1):41-7. Italian.

PMID:
10832525
44.

Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.

Oram RJ, Marcellino D, Strauss D, Gustafson E, Talarico CL, Root AK, Sharma PL, Thompson K, Fingeroth JD, Crumpacker C, Herold BC.

J Infect Dis. 2000 Apr;181(4):1458-61. Epub 2000 Apr 13.

PMID:
10762577
45.

[Acute biliary pancreatitis. Role of laparoscopy after 30 years of traditional surgery experience].

Zaraca F, Di Paola M, Gossetti F, Catarci M, Trentino P, Proposito D, Filippoussis P, Talarico E, Cerasoli V, Talarico C, Montemurro L, Carboni M.

Ann Ital Chir. 1999 Sep-Oct;70(5):705-11. Italian.

PMID:
10692791
46.

An improved technique for temporary diverting ileostomy.

Flati G, Talarico C, Carboni M.

Surg Today. 2000;30(1):104-5.

PMID:
10648097
47.

Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein.

Talarico CL, Burnette TC, Miller WH, Smith SL, Davis MG, Stanat SC, Ng TI, He Z, Coen DM, Roizman B, Biron KK.

Antimicrob Agents Chemother. 1999 Aug;43(8):1941-6.

48.

Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.

Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL, Kenney SC.

Cancer Res. 1999 Apr 1;59(7):1485-91.

49.

Emergence of a ganciclovir-resistant human cytomegalovirus strain with a new UL97 mutation in an AIDS patient.

Baldanti F, Simoncini L, Talarico CL, Sarasini A, Biron KK, Gerna G.

AIDS. 1998 May 7;12(7):816-8. No abstract available.

PMID:
9619816
50.

A simple ultrasonographic test for preoperative haemodynamic evaluation of varicocele.

Flati G, Flati D, La Pinta M, Porowska B, Talarico C, Carboni M.

Int Urol Nephrol. 1998;30(1):59-67.

PMID:
9569114

Supplemental Content

Loading ...
Support Center